The ARCS Annual Conference Healthcare 4.0 – the data imperative will be held from 21-23 August 2018 at Royal Randwick Racecourse, Sydney (NSW).

ARCS 2018 features over 80 individual sessions in 8 parallel streams covering regulatory affairs, clinical research, medical affairs and digital health topics across the pharmaceutical, biotech and medtech sectors. The conference also includes a dedicated executive leadership stream, poster presentation, social functions including the Awards Dinner and exhibition.

The ARCS Annual Conference is a must-attend event for people from the medtech, biotech and pharmaceutical sectors at all stages of their careers. It is expected that up to 1000 delegates will be attending this year.

The following themes will be discussed at the Annual Conference 2018:

Critical regulatory updates on prescription medicines, non-prescription medicines and medical devices:

With the continued government reform agenda and process updates, this year’s annual conference features critical updates from the Pharmacovigilance and Special Access, Medical Devices and Prescription Medicine Authorisation branches which include changes in the non-prescription medicines and TGA Advertising reforms. These sessions are complemented by updates from the relevant sector peak bodies and a broad range of practical session looking at eCTD, biosimilars, registers, clinical evidence report and GMP clearance.

Dedicated sessions to assist for Australian-based life science companies need to know about commercialisation:

With the growth of the Australian-based life science companies, this year sees the addition of a series of sessions presented by seasoned professionals which focused on providing valuable information for executives interested in getting a better understanding of positioning, regulatory and clinical development as well as pricing, reimbursement and market access.

Individualised care – are you across the latest development:

With the emergence of personalised medicine which tailors treatment to the unique needs, genetic make-up and lifestyle of each patient, this year see the inclusion of cutting-edge session which will tackle custom devices, the use of software as a therapeutic and precision medicine head-on and explore how this rapidly changing area will impact the way we bring therapeutics to the patient.

The changing reimbursement landscape:

With the ongoing reform agenda to give affordable and timely access to medicines and medical technologies, this year’s sessions provide discussion on the many challenges stakeholders are facing with the current reimbursement framework and examines, at both a policy and process level, the future direction and impacts of these changes to the funding the reimbursement of medicines and medical technologies.

Please access the ARCS website for more information: www.arcs.com.au